Mats Bogren Monica Soltesz Stephan Hjorth
10.3389/fpsyt.2022.887547
Front Psychiatry
2022 May 11;13:887547.
antipsychotic polypharmacy da d2/d3 partial agonism cognitive symptoms of schizophrenia negative symptoms (schizophrenia) psychosocial symptoms quality-of-life reward system
CC BY
https://pubmed.ncbi.nlm.nih.gov/35664491/
PMC9157048
35664491
Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder
2022